Add Yahoo as a preferred source to see more of our stories on Google. “This editorial board has long supported marijuana legalization. In 2014, we published a six-part series that compared the federal ...

The New York Times argued that it was “time to acknowledge reality” and “admit” that the United States has a “marijuana problem” in a new editorial admitting that the legalization of weed in most ...

Most SEO failures are not optimization failures. They are reasoning failures that occur before optimization even begins. In enterprise SEO escalations, the pattern is remarkably consistent. Teams jump ...

Amateur mathematicians are using artificial intelligence chatbots to solve long-standing problems, in a move that has taken professionals by surprise. While the problems in question aren’t the most ...

Along the bell curve of self-control, I sit somewhere in that far left quadrant. When attempting to change my own behavior, I’m a notoriously lenient boss, always willing to cut myself a little slack.

Imre Szenttornyay, CEO of Cielo IT LLC, empowers business owners to scale their operations profitably with AI-powered SmartSigns technology. When you manage a network of retail or franchise locations, ...

A friend of mine had just traveled across the country to see his family when he texted me, deeply concerned. The chaos of holiday travel is always a drag, but usually, it was offset by getting a break ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Kate Fitz-Gibbon has received funding for research on violence against women and children from a range of federal and state government and non-government sources, including Australia's National ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...